Skip to playerSkip to main content
  • 7 years ago
Swiss drugmaker Novartis has launched an international lottery for its groundbreaking and extremely costly gene therapy Zolgensma, sparking both hope and outrage among patients’ families.View on euronews

Category

🗞
News

Recommended